AIM To determine the antitumor effects of a new diterpene (petrisolide A, FA) against human promyeloxytic leukemia HL60
and erythroleukemia K562 cell lines in vitro. METHODS Antitumor activity was measured using IC50, cell growth curve and 3HTdR uptake. Simultaneously, the cell cycle was analysed by flow cytometric(FCM) technique and the
induced differentiation was tested by nitronblue tetrazolium(NBT) red uction. RESULTS IC50 of FA was 76 mg·L-1 to HL60 and 91 mg·L-1 to K562 respectively when incubation for 24 h. It obviously inhibited the growth curve of HL60 at 4 mg·L-1, the assays of 3HTdR incorporation into DNA showed a slight inhibition and the morphology was showed a cell damage under transmission electron microscopy (TEM) in the tumor cells of treated group. FCM analysis revealed that FA could arrest HL60 cells to G2+M phase and the S and G1 phase were not altered. In the tests of NBT reduction in the presence of FA at 4 mg·L-1 for 4 days, HL60 cells did not show NBT reductive ability. CONCLUSION FA remarkbly inhibited HL60 and K562 cell lines proliferation and showed a high antitumor activity. It was suggested that FA might inhibite mitoses of the cells and have not ability to induce
Differentiation.